At age 19, I was a medical student with big dreams — until stage 4 blood cancer changed everything, leading to a journey of ...

I share how hope, even when uncertain, helped me through cancer and honors its role in balancing realism, resilience and ...

June brought major prostate cancer updates, and CURE is sharing the latest FDA approvals, label expansions, and emerging data ...

After having a double mastectomy to rid myself of cancer, I’m less picky about how I look and won’t be wearing uncomfortable ...

Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.

Label updates have been approved by the FDA for the CAR T-cell therapies Breyanzi and Abecma in large B cell lymphoma and ...

CAR T-cell therapy may cure up to 40% of patients with lymphoma and is an option for those who can’t receive transplants, ...

An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns, ...

June brought major blood cancer updates, and CURE is sharing the latest in myelofibrosis treatment and FDA breakthroughs, as ...

I entered remission from lung cancer 5.5 years ago, but faced a tough road readjusting, with ongoing physical, mental and ...

June brought major breast cancer updates, and CURE is sharing the latest treatment combinations, biomarker-driven care and ...

I was diagnosed with testicular cancer at 20. I’ve learned to embrace the pauses in life and stand proud as a survivor who ...